anti-WT1 CAR T-cell therapy (Carsgen Therapeutics)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameanti-WT1 CAR T-cell therapy (Carsgen Therapeutics)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionWilms' Tumour 1 modulatorsT lymphocytes stimulantsImmunostimulants

TargetsWilms' Tumour 1

Therapy Area/IndicationsWilms Tumor

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaPending

Originator CompaniesCarsgen Therapeutics ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCarsgen Therapeutics ltd

Active IndicationsN/A

Inactive IndicationsWilms Tumor

Other Information

ATC CodeN/A